We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.3B
AUM Growth
-$1.95B
Cap. Flow
-$2.03B
Cap. Flow %
-16.47%
Top 10 Hldgs %
23.48%
Holding
1,965
New
109
Increased
648
Reduced
914
Closed
286

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$24.9M
2
PLTR icon
Palantir
PLTR
+$24.7M
3
APP icon
Applovin
APP
+$16.8M
4
MSTR icon
Strategy Inc
MSTR
+$12.4M
5
HD icon
Home Depot
HD
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 28.64%
2 Consumer Discretionary 9.28%
3 Healthcare 7.92%
4 Communication Services 7.89%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIW icon
1401
Highwoods Properties
HIW
$3.47B
$344K ﹤0.01%
11,257
-7,470
-40% -$243K
ABEV icon
1402
Ambev
ABEV
$46.4B
$344K ﹤0.01%
185,895
+2,770
+2% +$6.13K
AR icon
1403
Antero Resources
AR
$10.7B
$341K ﹤0.01%
9,743
-25,508
-72% -$772K
MMD
1404
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$282M
$341K ﹤0.01%
22,819
-66,036
-74% -$1.07M
OTTR icon
1405
Otter Tail
OTTR
$3.94B
$339K ﹤0.01%
4,597
-6,378
-58% -$499K
FMS icon
1406
Fresenius Medical Care
FMS
$12.9B
$339K ﹤0.01%
+14,980
New +$325K
AESI icon
1407
Atlas Energy Solutions
AESI
$1.41B
$338K ﹤0.01%
15,227
+4,558
+43% +$98.2K
BIO icon
1408
Bio-Rad Laboratories Class A
BIO
$9.42B
$334K ﹤0.01%
1,018
-612
-38% -$208K
ALX
1409
Alexander's
ALX
$1.41B
$334K ﹤0.01%
1,667
-41
-2% -$9.07K
ACMR icon
1410
ACM Research
ACMR
$5.79B
$332K ﹤0.01%
+21,981
New +$397K
IPGP icon
1411
IPG Photonics
IPGP
$3.84B
$330K ﹤0.01%
4,542
-4,665
-51% -$358K
PMT
1412
PennyMac Mortgage Investment
PMT
$842M
$329K ﹤0.01%
26,115
+3,810
+17% +$51.5K
HLIT icon
1413
Harmonic Inc
HLIT
$1.28B
$328K ﹤0.01%
+24,788
New +$323K
WWD icon
1414
Woodward
WWD
$21.4B
$326K ﹤0.01%
1,959
+542
+38% +$92.6K
HPS
1415
John Hancock Preferred Income Fund III
HPS
$458M
$325K ﹤0.01%
+21,652
New +$345K
CRGY icon
1416
Crescent Energy
CRGY
$3.82B
$324K ﹤0.01%
+22,190
New +$301K
RY icon
1417
Royal Bank of Canada
RY
$293B
$324K ﹤0.01%
2,687
+566
+27% +$69.9K
NTCT icon
1418
NETSCOUT
NTCT
$2.79B
$323K ﹤0.01%
+14,917
New +$323K
MZTI
1419
The Marzetti Company
MZTI
$3.11B
$323K ﹤0.01%
1,864
-512
-22% -$93.7K
Z icon
1420
Zillow
Z
$7.56B
$322K ﹤0.01%
4,355
-1,236
-22% -$88.4K
SRTA
1421
Strata Critical Medical Inc
SRTA
$512M
$322K ﹤0.01%
75,810
-13,282
-15% -$50.6K
SRRK icon
1422
Scholar Rock
SRRK
$6.44B
$322K ﹤0.01%
+7,440
New +$242K
AAP icon
1423
Advance Auto Parts
AAP
$3.49B
$322K ﹤0.01%
6,799
-66,610
-91% -$2.71M
ATR icon
1424
AptarGroup
ATR
$8.61B
$320K ﹤0.01%
2,036
-361
-15% -$60.3K
CVE icon
1425
Cenovus Energy
CVE
$52.1B
$318K ﹤0.01%
20,974
+908
+5% +$14.6K

Similar funds

Guggenheim Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Guggenheim Capital held 1,965 positions worth $12.3B, down 14% from $14.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Guggenheim Capital withdrew a net $2.03B in Q4 2024, closing 286 positions and reducing 914 holdings. Its most notable exit was MGP Ingredients, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Guggenheim Capital opened a new position in iShares Core S&P 500 ETF worth $24.8M.

  • Guggenheim Capital's largest Q4 2024 buy was iShares Core S&P 500 ETF: 42,150 shares worth $24.8M.
  • Guggenheim Capital added most to Palantir in Q4 2024, an estimated $24.7M increase.
  • Guggenheim Capital's biggest Q4 2024 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $183M.
  • Guggenheim Capital fully exited MGP Ingredients in Q4 2024, selling an estimated $13.5M.
  • Guggenheim Capital's ten largest holdings make up 23% of its $12.3B portfolio in Q4 2024.
  • Guggenheim Capital opened 109 new positions and closed 286 in Q4 2024.
  • Guggenheim Capital's portfolio value fell 14% quarter-over-quarter to $12.3B.

Based on Guggenheim Capital's 13F filing for Q4 2024, filed 13 Feb 2025.